Hypoxia inducible factors in hepatocellular carcinoma
Metrics: PDF 1314 views | HTML 4979 views | ?
Chu Chen1, Tao Lou1
1Department of Internal Medicine, Fourth Affiliated Hospital of Zhejiang University, School of Medicine, Yiwu, 322000, Zhejiang, China
Tao Lou, email: firstname.lastname@example.org
Keywords: liver cancer, hepatoma, HIF, hypoxia, therapy
Received: February 13, 2017 Accepted: April 04, 2017 Published: April 21, 2017
Hepatocellular carcinoma is one of the most prevalent and lethal cancers with limited therapeutic options. Pathogenesis of this disease involves tumor hypoxia and the activation of hypoxia inducible factors. In this review, we describe the current understanding of hypoxia signaling pathway and summarize the expression, function and target genes of hypoxia inducible factors in hepatocellular carcinoma. We also highlight the recent progress in hypoxia-targeted therapeutic strategies in hepatocellular carcinoma and discuss further the future efforts for the study of hypoxia and/or hypoxia inducible factors in this deadly disease.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.